Skip to main content
. 2020 Jan 13;8(1):13. doi: 10.3390/biomedicines8010013
AD Alzheimer’s disease
PD Parkinson’s disease
PLA Polylactic acid
PGA Polyglycolic acid
PLGA Poly D,L-lactide-co-glycolide
PVA Polyvinyl alcohol
PCL Poly (ε-caprolactone)
PNPCL Poly (N-isopropylacrylamide)-b-poly(3-caprolactone)
PACA Poly (alkyl cyanoacrylate)
PBCA Poly (butyl cyanoacrylate)
PEG Polyethylene glycol
P80 Polysorbate 80
P188 Poloxamer 188
HSA Human serum albumin
CS Chitosan
CPP Cell-penetrating peptides
BBB Blood–brain barrier
CNS Central nervous system
GE Gelatin
NDDs Neurodegenerative diseases
MS Multiple sclerosis
NPs Nanoparticles
RES Reticuloendothelial system
ROS Reactive oxygen species
SOD Superoxide dismutase
CSF Cerebrospinal fluid
IV Intravenous
IN Intranasal
MDR Multidrug resistance
NT-1 Neurotoxin-I
TRH Thyrotropin-releasing hormone
Lf Lactoferrin
LDLR Low-density lipoprotein receptor
DOX Doxorubicin
Amyloid beta
GABA Gamma-aminobutyric acid
TMZ Temozolomide
Tf Transferrin
TMC Trimethylated chitosan (TMC)
GCTB Gemcitabine
NGF Nerve growth factor
Apo Apolipoprotein
IFNβ-1b Interferon β-1b